Genitope Corporation
Records under this name other than patents Genitope Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Genitope Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,419,660 | Vaccines for treatment of lymphoma and leukemia Term ended Term ended May 1, 2016 · From the USPTO record | Term ended | Term ended May 1, 2016 | From the USPTO record |
| US 7,208,146 | Methods of treating lymphoma and leukemia Lapsed on the fee record Ended Apr 24, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2015 | From the USPTO record |
| US 7,405,060 | Gene amplification methods Lapsed on the fee record Ended Jul 29, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 29, 2012 | From the USPTO record |
| US 5,776,746 | Gene amplification methods Term ended Term ended no later than Jul 7, 2018 · Low confidence | Term ended | Term ended no later than Jul 7, 2018 | Low confidence |
| US 5,972,334 | Vaccines for treatment of lymphoma and leukemia Term ended Term ended no later than Oct 26, 2019 · Low confidence | Term ended | Term ended no later than Oct 26, 2019 | Low confidence |